Ophthalmic compositions and their use for treating elevated intr

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514913, A61K 2700

Patent

active

045214140

ABSTRACT:
Antiglaucoma compositions that contain enriched R-(+)-1-tert-butylamino-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]-2-prop anol compared to the S-(-)-isomer and the ophthalmologically acceptable acid addition salts thereof are useful in methods for treating glaucoma and elevated intraocular pressure.

REFERENCES:
patent: 3655663 (1972-04-01), Wasson
patent: 3833727 (1974-09-01), Nelson et al.
patent: 3891639 (1975-06-01), Wasson
patent: 3940407 (1976-02-01), Muchowski et al.
patent: 4097490 (1978-06-01), Reinhold
patent: 4195085 (1980-03-01), Stone
Chem. Abst. 85, 87486(q) (1976)--Katz et al.
"Timoptic"-A.H.F.S. Category 52:36--Aug. 1978-Merck & Co. Inc.
Biochem. Pharm. 30, 103-106, (1981) (Chiou).
Explt. Eye Res (1970) 9, 82-90, Vale et al.
Brit. J. Ophthal (1973) 57,2310, Vale et al.
Kass, M. A. et al., "The Effect of D-isoproterenol on IOP of Rabbit, Monkey, and Man," Inv. Ophthalmol., 15, 113 (1976).
Rowland, J. M. and Potter, D. E., "Adrenergic Drugs and IOP: Effects of D-isomers of Various Agonists", Curr. Eye Res., 1, 25 (1981).
Seidehamel, R. J. et al., "Specific Hypotensive and Antihypertensive Ocular Effects of D-isoproternol in Rabbits", Am. J. Ophthalmol., 79, 1018-1025 (1975).
Physicians' Desk Reference, "Timoptic.RTM. Sterile", pp. 1199-1200.
Goodman & Gilman's The Pharmacological Basis of Therapeutics, 6th Ed., Macmillan Publishing Co., Inc., N.Y. 144 (1980).
Meyers, F. H., Jawetz, E. and Goldien, A., Review of Medical Pharmacology, Lange Med. Publishing, Los Altos, CA., 80 (1978).
Drill's Pharmacology in Medicine, McGraw-Hill Book Co., N.Y. 464 (1968).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Ophthalmic compositions and their use for treating elevated intr does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ophthalmic compositions and their use for treating elevated intr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ophthalmic compositions and their use for treating elevated intr will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-828243

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.